Endoscopic Closure of Tracheoesophageal Fistulas With Occluder Device (TEFGoreHelex)
Endoscopic Closure of Tracheoesophageal Fistulas With a Cardiac Septal Defect Occluder
Sponsor: InCor Heart Institute
Terminated
The study was terminated because the rate of prothesis dislocation was too high.
Other terminated trials from InCor Heart Institute
Listed as NCT01153061, this PHASE4 trial focuses on Acquired Tracheo-esophageal Fistula and remains terminated or withdrawn. Sponsored by InCor Heart Institute, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE4
First recorded
Jun 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- InCor Heart Institute
- University of Sao Paulo
- W.L.Gore & Associates
For direct contact, visit the study record on ClinicalTrials.gov .